An Update on Glucagon

Less than ten percent of people filled a glucagon prescription after a hospitalization due to hypoglycemia. In the past few years, a slew of new glucagon products have come to market. Join host, Geoff Wall, as he discusses how to optimize glucagon therapy with diabetes expert, Jamie Pitlick.The GameChangerDespite glucagon products being proven safe and effective, they are severely under-prescribed and underutilized.  Patients that are at risk for level 2 or 3 hypoglycemia should be prescribed glucagon.Did you know poisons have been used as murder weapons throughout human history? Join us on November 10th at 7 PM CT for a free, live CE on Murder with Medications exclusively on the CEimpact App. It's free to join! You'll learn about medical professionals who used their access to medications to commit murder. It's fascinating and unimaginable. Sign up here!Show Segments00:00 - Introductions01:54 - The Risk of Hypoglycemia10:45 - GameChanger: New Glucagon Products20:40 - Connecting to Practice: What Practitioners Should Know25:11 - Closing RemarksHostGeoff Wall, PharmD, BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthGuestJamie Pitlick, Pharm.D., BCPS, BC-ADMAssociate Professor, Pharmacy PracticeDrake University College of Pharmacy and Health SciencesReferences and ResourcesGlucaGen - Plainsboro, NJ: Novo Nordisk.  Revised in March 2021. Glucagon - Indianapolis, IN. Eli Lily USA. Zegalogue - Denmark: Zealand Pharma. Revised April 2021. Baqsimi - Indianapolis, IN: Eli Lily.  Revised October, 2020. GVOKE - Chicago, IL: Xeris Pharmaceuticals.   Revised August 2021Redeem your CPE or CME hereCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the risk of hypoglycemia for patients with diabetes2. Describe the differences in the glucagon products on the market in the US0.05 CEU/0.5 HrUAN: 0107-0000-22-402-H01-PInitial release date: 11/07/2022Expiration date: 11/07/2023Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram